Celldex Therapeutics
CLDX
#4620
Rank
NZ$3.94 B
Marketcap
NZ$50.17
Share price
-1.68%
Change (1 day)
13.04%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): NZ-$7.56

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$7.94. In 2025 the company made an earnings per share (EPS) of NZ-$7.10 a decrease over its 2024 EPS that were of NZ-$4.47.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$7.566.42%
2025NZ-$7.1058.78%
2024NZ-$4.47
2022NZ-$4.3645.73%
2021NZ-$2.99-23.36%
2020NZ-$3.91-41.05%
2019NZ-$6.63-76.95%
2018NZ-$28.75
2016NZ-$34.49-3.82%
2015NZ-$35.86-0.76%
2014NZ-$36.14
2012NZ-$27.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.30-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.72-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.25-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
NZ-$8.01 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ-$7.32-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$3.69-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$9.20 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA